<unk> , also known as<unk>  sodium, and sold under the brand name Cerebyx among others, is a water-soluble phenytoin prodrug that is administered intravenously to deliver phenytoin, potentially more safely than intravenous phenytoin. It is used in the acute treatment of convulsive status epilepticus.<unk>  was developed in 1996. On 18 November 2004, Sicor (a subsidiary of Teva) received a tentative approval letter from the United States Food and Drug Administration for a generic version of<unk> .
Fosphenytoin
Phenytoin
Mephenytoin
Mesuximide
Levetiracetam
Lamotrigine
Phenylpiracetam
Ethosuximide